6 May 2026Open access1cites
Synergistic phytochemicals in multi-target drug discovery for complex diseases: A narrative reviewPublisher sitePhytomedicine Plus, Computational Drug Discovery Methods
UniversitiesUgwu Melvin Nnaemeka
Active, last published 2026
In natural antidiabetic agents studies
Ugwu Melvin
Nnaemeka
Scholar“Research focused on Natural Antidiabetic Agents Studies and adjacent fields.”
Claim Your Profile5
H-index
133
Citations
Ugwu has not officially claimed their profile. If you are Ugwu, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
gwu Melvin Nnaemeka is a researcher working on Natural Antidiabetic Agents Studies. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Ugwu's work has been cited 133 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Natural Antidiabetic Agents Studies×16Drug-Induced Hepatotoxicity and Protection×7Papaya Research and Applications×4Gut microbiota and health×3Phytochemical and Pharmacological Studies×3
04 · Where I am
Affiliations
Affiliation details will appear once this profile is updated.
05 · Selected work
Recent publications
2 works2 Apr 2026Open access
Nano-enhanced phytomedicine: A review of nanocarrier systems for targeted delivery of plant-derived bioactives in chronic disease therapyPublisher sitePhytomedicine Plus, Curcumin's Biomedical Applications
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ugwu?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you